VivaTech, Paris, 17 June 2026 – From June 17-20, Withings, a pioneer in connected health and inventor of the first connected scale, will unveil BodyScan 2 at Vivatech, its new connected health and longevity station. The first and only consumer solution which offers a complete cardiac, vascular, and metabolic analysis with DEXA-level body composition accuracy, it delivers a personalised assessment in just 90 seconds, displayed in real time on its new HD screen integrated into the handle. Visitors will be able to discover and test this innovation at the Withings booth.
At VivaTech 2026, Europe’s largest innovation event, Withings will showcase BodyScan 2, which has been available in Europe since 9 June 2026. One week after its commercial launch, VivaTech represents the first time it will have been showcased in Europe.
Awarded a CES 2026 Innovation Award, BodyScan 2 ushers in a new generation of connected health devices designed to help users detect early signs of cardiovascular and metabolic health right at home.
A complete health check in 90 seconds
Visitors of the Withings booth can have a comprehensive health check using BodyScan 2. The device analyses all biomarkers in just 90 seconds and provides data related to body composition, cardiovascular health, and metabolism.
Available indicators include:
● Segmental body composition analysis across 6 zones using 13-frequency BIS technology
● Tracking of muscle mass, bone mass, body water, and visceral fat
● Glycemic resilience score and nerve response score
● Hypertension notifications
● Cardiovascular age measurement
● Clinically validated 6-lead ECG with atrial fibrillation detection
● Longitudinal blood oxygenation (SpO₂) monitoring
When preventive health comes to VivaTech
With artificial intelligence and precision health among the major themes of the 2026 edition of VivaTech, Withings will present its vision of more proactive health, based on the identification of physiological signals often invisible before the onset of the first symptoms.
BodyScan 2 combines technologies previously reserved for clinical settings, including impedance cardiography (ICG), with advanced body composition analysis and health tracking algorithms developed by Withings.
VivaTech practical information
June 17-20, 2026
Paris Expo Porte de Versailles
Withings booth: Hall 7.1 – Aisle A – No. 11
About Withings
A pioneer in real-life health monitoring, Withings created the first connected scale in 2009 and has continually innovated since then to offer an ecosystem of clinically validated connected objects, used by 12 million people worldwide, as well as by numerous renowned healthcare centers and research institutes. The Withings ecosystem measures over 90 biomarkers. It includes a sleep analyzer that detects sleep cycles, wake phases, and sleep apnoea. It also features hybrid connected watches that notably track heart rate and its variations day and night, perform a medical-grade electrocardiogram to detect pathologies like atrial fibrillation, or monitor blood oxygenation. Its connected blood pressure monitors allow for home monitoring of blood pressure evolution, thanks to sharing reliable and exhaustive measurement reports with a doctor, and can integrate a stethoscope to detect at-home valvular heart disease, which is more frequent in cases of arterial hypertension.
To learn more, visit withings.com
